Bioresearch Monitonoring Information System (BMIS)

Metadata Updated: April 21, 2021

This contains information that identifies clinical investigators, contract research organizations, and institutional review boards involved in the conduct of Investigational New Drug (IND) studies with human investigational drugs and therapeutic biologics.

Access & Use Information

Public: This dataset is intended for public access and use. License: See this page for license information.

Downloads & Resources

Dates

Metadata Created Date November 10, 2020
Metadata Updated Date April 21, 2021

Metadata Source

Harvested from Healthdata.gov

Additional Metadata

Resource Type Dataset
Metadata Created Date November 10, 2020
Metadata Updated Date April 21, 2021
Publisher U.S. Food and Drug Administration
Unique Identifier Unknown
Maintainer
Identifier 8d346d8d-33c7-47f8-890d-a4ced16e45dd
Data First Published 2021-02-25
Data Last Modified 2013-08-29
Public Access Level public
Bureau Code 009:10
Metadata Context https://project-open-data.cio.gov/v1.1/schema/catalog.jsonld
Metadata Catalog ID https://healthdata.gov/data.json
Schema Version https://project-open-data.cio.gov/v1.1/schema
Catalog Describedby https://project-open-data.cio.gov/v1.1/schema/catalog.json
Harvest Object Id 5704902b-54de-4d72-a10c-e1c02ac2504b
Harvest Source Id 651e43b2-321c-4e4c-b86a-835cfc342cb0
Harvest Source Title Healthdata.gov
Homepage URL http://www.fda.gov/Drugs/InformationOnDrugs/ucm135162.htm
License http://opendefinition.org/licenses/odc-odbl/
Program Code 009:002
Source Datajson Identifier True
Source Hash f9c8e81fee64bd799f4e76a6e21b99b8a2e135cc
Source Schema Version 1.1

Didn't find what you're looking for? Suggest a dataset here.